Benign metanephric tumor

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

Regulatory Watchboard

No FDA or trial events recorded yet for Benign metanephric tumor.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

XGEVA

Amgen, Inc.

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

XGEVA

(denosumab)Orphan drugstandard

Amgen, Inc.

RANK Ligand Inhibitor [EPC]

12.1 Mechanism of Action Xgeva binds to RANKL, a transmembrane or soluble protein essential for the formation, function, and survival of osteoclasts, ...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Benign metanephric tumor.
Search all trials →
Search clinical trials for Benign metanephric tumor

Recent News & Research

No recent news articles indexed yet for Benign metanephric tumor.
Search PubMed for Benign metanephric tumor

Browse all Benign metanephric tumor news →

Specialist Network

No specialists currently listed for Benign metanephric tumor.

View all Benign metanephric tumor specialists →

Quick Actions